Anacor Pharmaceuticals, Inc.·4

Feb 4, 4:10 PM ET

Anacor Pharmaceuticals, Inc. 4

4 · Anacor Pharmaceuticals, Inc. · Filed Feb 4, 2015

Insider Transaction Report

Form 4
Period: 2015-02-02
Maples Kirk R
Senior VP Program Mgt
Transactions
  • Sale

    Common Stock

    2015-02-02$37.41/sh600$22,4484,600 total
Footnotes (3)
  • [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $37.07 to $37.68, inclusive.
  • [F3]Includes 1,000 shares purchased on January 30, 2015 pursuant to the Issuer's ESPP.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION